Vectura Group PLC  

(Public, LON:VEC)   Watch this stock  
Find more results for Thomas J. Oakley
150.20
+0.40 (0.27%)
Real-time:   4:24PM GMT+1
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 146.10 - 150.79
52 week 145.30 - 200.10
Open 149.40
Vol / Avg. 665,428.00/2.31M
Mkt cap 1.01B*
P/E 131.41
Div/yield     -
EPS 0.01*
Shares 410.62M
Beta     -
Inst. own     -
*GBP
May 26, 2016
Full Year 2016 Vectura Group PLC Earnings Call
May 26, 2016
Full Year 2016 Vectura Group PLC Earnings Release
  

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin 16.78% 6.94%
Operating margin 2.61% -7.08%
EBITD margin - 28.75%
Return on average assets 5.56% 1.73%
Return on average equity 6.67% 2.18%
Employees 270 -
CDP Score - 66 E

Address

One Prospect West
CHIPPENHAM, SN14 6FH
United Kingdom - Map
+44-1249-667700 (Phone)
+44-1249-667701 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Vectura Group plc is a product development company. The Company focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases (airways diseases). The Company has eight products marketed by its partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies. Its portfolio comprises partnered and licensed marketed products, as well as branded and generic investigational drugs. It has various products in the pipeline, which include VR588, VR942, VR475, VR465, VR096, VR647, VR179, VR736, VR876, NVA237, QVA149, VR315, VR506 and VR632. Its marketed products include Ultibro Breezhaler, Seebri Breezhaler, AirFluSal Forspiro, ADVATE and Adept. Its licensed products include Anoro Ellipta, Relvar Ellipta/Breo Ellipta and Incruse Ellipta. It also has a range of technology platforms, which include formulation technologies, such as PowderHale and ParticleMAX, and device technology, such as GyroHaler.

Officers and directors

James Ward-Lilley Chief Executive Officer, Executive Director
Frank C. Condella Jr. Vice Chairman of the Board
Andrew J. Oakley Group Chief Financial Officer, Executive Director, Company Secretary
Age: 54
Andrew Derodra Chief Financial Officer, Director
Age: 49
Trevor Michael Phillips Ph.D. Chief Operating Officer, President - US Operations, Director
Age: 54
Joanne Hombal Director of Human Resources
Age: 41
Roger Heerman Chief Commercial Officer
Age: 42
Karl D. Keegan Ph.D. Chief Corporate Development Officer
Age: 48
Bruno F. J. Angelici Non-Executive Chairman of the Board
Age: 69
Per-Olof Andersson Non-Executive Director
Age: 62